Citigroup’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $350 | Sell |
321
-21,586
| -99% | -$23.5K | ﹤0.01% | 4708 |
|
|
2025
Q1 | $21.3K | Sell |
21,907
-1,822
| -8% | -$1.77K | ﹤0.01% | 4309 |
|
|
2024
Q4 | $35.1K | Buy |
23,729
+718
| +3% | +$1.06K | ﹤0.01% | 4327 |
|
|
2024
Q3 | $48.8K | Buy |
23,011
+16,220
| +239% | +$34.4K | ﹤0.01% | 4250 |
|
|
2024
Q2 | $16.6K | Sell |
6,791
-64,765
| -91% | -$158K | ﹤0.01% | 4304 |
|
|
2024
Q1 | $464K | Buy |
+71,556
| New | +$464K | ﹤0.01% | 2908 |
|
|
2023
Q1 | – | Sell |
-74
| Closed | -$152 | – | 4815 |
|
|
2022
Q4 | $152 | Sell |
74
-353
| -83% | -$725 | ﹤0.01% | 4810 |
|
|
2022
Q3 | $2K | Sell |
427
-309
| -42% | -$1.45K | ﹤0.01% | 4692 |
|
|
2022
Q2 | $3K | Sell |
736
-1,946
| -73% | -$7.93K | ﹤0.01% | 4982 |
|
|
2022
Q1 | $12K | Sell |
2,682
-5,238
| -66% | -$23.4K | ﹤0.01% | 4650 |
|
|
2021
Q4 | $94K | Buy |
7,920
+7,053
| +813% | +$83.7K | ﹤0.01% | 4000 |
|
|
2021
Q3 | $15K | Sell |
867
-1,149
| -57% | -$19.9K | ﹤0.01% | 4595 |
|
|
2021
Q2 | $35K | Buy |
+2,016
| New | +$35K | ﹤0.01% | 4311 |
|